10204 related articles for article (PubMed ID: 16831290)
1. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
2. Vasculogenic mimicry: current status and future prospects.
Zhang S; Zhang D; Sun B
Cancer Lett; 2007 Sep; 254(2):157-64. PubMed ID: 17306454
[TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
[TBL] [Abstract][Full Text] [Related]
4. Molecular plasticity of human melanoma cells.
Hendrix MJ; Seftor EA; Hess AR; Seftor RE
Oncogene; 2003 May; 22(20):3070-5. PubMed ID: 12789282
[TBL] [Abstract][Full Text] [Related]
5. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
6. Vasculogenic mimicry.
Folberg R; Maniotis AJ
APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
Sun B; Zhang S; Zhao X; Zhang W; Hao X
Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
[TBL] [Abstract][Full Text] [Related]
8. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
Hess AR; Seftor EA; Seftor RE; Hendrix MJ
Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
Bhat P; Jakobiec FA; Folberg R
Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
[TBL] [Abstract][Full Text] [Related]
12. [Vasculogenic mimicry in the bi-directional differentiation malignant tumors of digestive tract].
Gu XM; Li YQ; Zhao YA
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2398-400. PubMed ID: 18036316
[TBL] [Abstract][Full Text] [Related]
13. The involvement of apoptosis in melanoma vasculogenic mimicry.
Vartanian AA; Burova OS; Stepanova EV; Baryshnikov AY
Melanoma Res; 2007 Feb; 17(1):1-8. PubMed ID: 17235236
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of vasculogenic mimicry in colorectal cancer.
Baeten CI; Hillen F; Pauwels P; de Bruine AP; Baeten CG
Dis Colon Rectum; 2009 Dec; 52(12):2028-35. PubMed ID: 19934926
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of the receptor tyrosine kinase EphA2 in choroidal melanoma: correlation with vesculogenic mimicry and prognosis].
Chen LX; Sun BC; Li XR; He YJ; Song GX
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):985-90. PubMed ID: 23302271
[TBL] [Abstract][Full Text] [Related]
16. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
17. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between the expression of collgen IV, VEGF and vasculogenic mimicry].
Hao XS; Sun BC; Zhang SW; Zhao XL
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):524-6. PubMed ID: 14690552
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.
Hess AR; Margaryan NV; Seftor EA; Hendrix MJ
Dev Dyn; 2007 Dec; 236(12):3283-96. PubMed ID: 17557303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
